Best Cancer Hospital in India for Australian Patients: JCI-Certified Care in 2026

Australia has world-class cancer care. Peter MacCallum Cancer Centre in Melbourne ranks 16th in the world. Royal Brisbane, Royal Prince Alfred, and five other Australian public hospitals appear in the Newsweek 2025 top-300. If you can access these centres, you should.

But many Australian cancer patients face real problems. In many states, you wait 30–50 days just to see a public oncology specialist. Private cancer care — for complex surgery, proton therapy, or long-course immunotherapy — can cost AUD $50,000–$200,000+ without good insurance. India’s JCI-accredited cancer centres use the same clinical methods. They have the same technology. Their doctors trained overseas. They cost 60–80% less. This guide gives you the honest comparison.

What Makes a Cancer Hospital Truly “the Best”?

“Best” in cancer care is not one simple thing. The Newsweek global rankings use three things: votes from medical experts worldwide, hospital accreditation status, and patient outcome scores. A hospital that scores well in the expert vote may not be the best choice for your specific cancer type, your stage, or your budget.

Accreditation, Technology, and Specialisation: What to Look For

Four things set the best cancer centres apart from the rest.

First: accreditation. JCI (Joint Commission International) checks hospitals against the same safety standards used in the US and Europe. NABH (National Accreditation Board for Hospitals) is India’s national standard. Both require a formal on-site check and regular surprise re-visits.

Second: a multidisciplinary team (MDT). Top centres hold tumour board meetings. At these meetings, your oncologist, surgeon, radiation doctor, pathologist, and radiologist all review your case together. They decide on treatment as a group, not alone.

Third: clinical trial access. Hospitals running phase II and III trials get earlier access to new treatments.

Fourth: specialisation depth. A centre that treats 500 pancreatic cancer cases a year gets better results than one that treats 30.

If you are looking at Indian centres, ask these questions: How many cases of your cancer type do they treat each year? Do they have a tumour board for your cancer? Have their oncologists trained overseas? Many at Apollo, Medanta, and Fortis trained in the UK, USA, or Germany. Do they publish their 5-year survival rates?

JCI and NABH Accreditation: What They Mean for Your Safety

JCI-accredited hospitals have passed checks on 1,200+ standards. These cover patient ID, medication safety, infection control, surgical steps, and quality improvement. JCI accreditation is not a marketing claim — you cannot self-award it. It is voluntary, checked by an external team, and renewed every three years. Apollo Hospitals Chennai, Medanta Gurgaon, and Fortis Memorial Research Institute all hold current JCI accreditation.

NABH (National Accreditation Board for Hospitals) is India’s government-backed quality standard. MAX Hospitals Delhi and Artemis Gurgaon both hold it. Like JCI, NABH uses surprise inspections. Indian hospitals must also meet NABH standards under India’s Clinical Establishments Act.

What Is the Best Oncology Hospital in Australia?

Peter MacCallum Cancer Centre in Melbourne is Australia’s top dedicated cancer centre. It is one of only a few hospitals outside North America and Europe in the global top 20. In the Newsweek 2025 rankings, Peter Mac came in at #16 — behind MD Anderson (#1) and Memorial Sloan Kettering (#2), but ahead of many European centres.

The ranking uses votes from medical experts worldwide, plus accreditation data and patient outcome scores. Peter Mac has formal partnerships with MD Anderson, Dana-Farber (#15), and Princess Margaret Cancer Centre in Toronto (#11). 

Hospital	Newsweek 2025 Rank	City / Notes
Peter MacCallum Cancer Centre	#16 (Top 20 globally)	Melbourne — Australia's leading comprehensive cancer centre
Royal Brisbane and Women's Hospital	#123	Brisbane — strong in colorectal and gynaecological oncology
Austin Hospital	#141	Melbourne — haematology and BMT specialisation
Royal Prince Alfred Hospital	#163	Sydney — melanoma and liver cancer programmes
Westmead Hospital	#200	Sydney — breast cancer and oncological surgery
Royal Melbourne Hospital CCC	#272	Melbourne — lung and head & neck cancer
The Alfred	#278	Melbourne — blood cancers, bone marrow transplant

 Source: This information comes from Newsweek World's Best Specialized Hospitals 2025 — Oncology category, as reported by Oncology Republic Australia (September 2024). The rankings are based on a survey conducted in 2024; verify current rankings at newsweek.com.

Why does this matter for patients thinking about India? It sets the benchmark. Indian JCI-accredited cancer centres are not trying to beat Peter Mac in the rankings. They offer the same clinical tools — robotic surgery, LINAC radiation, immunotherapy, molecular testing — at a much lower cost. Wait times are shorter too. If you are waiting 6–8 weeks for a Peter Mac spot, or facing a $150,000 private bill, India’s JCI hospitals may be a sound clinical and financial choice.

The World’s Top Cancer Hospitals in 2025: Where India Fits.

#	Hospital	Country	Known For
1	MD Anderson Cancer Center	USA (Houston)	Immuno-oncology, proton therapy, clinical trials
2	Memorial Sloan Kettering Cancer Center	USA (New York)	Surgical oncology, genomic medicine
3	The Royal Marsden NHS Foundation Trust	UK (London)	Haematological cancers, targeted therapy research
4	Dana-Farber Cancer Institute	USA (Boston)	Haematology, CAR-T therapy
5	Institut Gustave Roussy	France (Paris)	Solid tumours, precision oncology
11	Princess Margaret Cancer Centre	Canada (Toronto)	Radiation oncology, genomics
15	Dana-Farber / Brigham & Women's	USA (Boston)	Breast cancer, PGT programmes
16	Peter MacCallum Cancer Centre ⭐ AUS	Australia (Melbourne)	Surgical oncology, CAR-T, haematology
20+	National Cancer Centre Singapore	Singapore	Asian cancer types, clinical access from AU
—	Apollo Hospitals / Medanta / Fortis (India)	India	JCI/NABH-accredited; comparable clinical protocols at 60–80% lower cost than Western peers

Source: Newsweek World's Best Specialized Hospitals 2025 — Oncology ranking. Indian hospitals are not currently included in the Newsweek top-100 oncology list, which is based predominantly on peer recommendations from Western medical professionals. This shows a survey methodology bias, not a clinical quality assessment. Verify current rankings at newsweek.com/rankings/worlds-best-specialized-hospitals-2025/oncology.

A note on this table: the Newsweek ranking is a survey of medical professionals. Most of those surveyed work in Western countries. So Indian oncology centres are underrepresented. Indian hospitals not appearing in the top-100 is a gap in the survey method — not a judgment on clinical quality. Indian JCI centres publish 5-year survival rates for major cancer types. These rates match global benchmarks. You can request this data from Apollo Hospitals, Medanta, and Fortis.

Specialised Cancer Centres: Paediatric, Breast, and Colorectal

Specialised cancer programmes matter. When a centre treats more cases of one cancer type, outcomes improve. In India, several JCI-accredited hospitals have built strong specialisation programmes. Apollo Hospitals Chennai’s bone marrow transplant (BMT) unit treats over 300 BMT cases a year. Medanta Gurgaon’s Cancer Institute has dedicated surgery for head and neck, chest, and gut cancers. Fortis Memorial Research Institute is especially strong in blood cancers — including CML, ALL, and lymphomas.

For children’s cancer care, following the right treatment steps and offering emotional support are both critical. Apollo Hospitals Chennai runs one of India’s largest children’s cancer units. They follow Children’s Oncology Group (COG) guidelines. MAX Healthcare Delhi also has a dedicated children’s cancer team. Both hospitals have clear pathways for international families travelling with children.

What Are the Main Cancer Treatments Available in India?

Modern cancer treatment rarely uses just one approach. The Divinheal partner hospitals offer the full range of treatments used by leading centres worldwide. The table below shows the main treatment types available in India:

Treatment Type	How It Works	Typical Cancers Treated
Surgery.	Physical removal of the tumour and surrounding tissue. May be open or minimally invasive (laparoscopic/robotic).	Breast, colorectal, gynaecological, lung, head & neck, prostate.
Chemotherapy.	Drugs that kill rapidly dividing cancer cells, administered intravenously or orally. Often given in cycles.	Leukaemia, lymphoma, breast, lung, ovarian, colorectal.
Radiation Therapy (IMRT/SBRT).	High-energy beams precisely targeted at tumour. SBRT delivers high doses in fewer sessions (3–5 vs 30+).	Brain, prostate, lung, liver, spine, head & neck.
Targeted Therapy.	Drugs that attack cancer-specific genetic mutations (e.g., HER2, EGFR, BRAF). Requires prior genetic testing.	Breast (HER2+), lung (EGFR/ALK), melanoma (BRAF), CML.
Immunotherapy.	Activates the immune system to identify and destroy cancer cells. Includes checkpoint inhibitors (PD-1/PD-L1) and CAR-T therapy.	Melanoma, lung, bladder, lymphoma, some colorectal (MSI-H).
Proton Therapy.	Proton beams stop precisely at the tumour depth, sparing surrounding tissue. Requires specialist facility.	Paediatric brain tumours, skull base, prostate, spine near spinal cord.

Your treatment options depend on your cancer type, stage, and overall health. A qualified oncologist  must make all treatment decisions after a full assessment. India’s JCI-accredited centres follow NCCN and ESMO treatment guidelines. 

Targeted Therapy and Immunotherapy: India’s Growing Capability

Targeted therapy and immunotherapy are the biggest advances in cancer care in the last decade. Their use in India has grown fast. Most JCI-accredited Indian centres now offer the main checkpoint inhibitors — pembrolizumab/Keytruda, nivolumab/Opdivo, atezolizumab/Tecentriq. They also offer targeted drugs for HER2+ breast cancer, EGFR-mutant lung cancer, BRAF-mutant melanoma, and CML.

To find the right targeted treatment, you first need genetic testing. Apollo, Medanta, and Fortis run next-generation sequencing (NGS), IHC, and FISH tests in-house. Results are usually back in 7–14 days.

CAR-T cell therapy is one of the most advanced forms of immunotherapy. It is available at Apollo Hospitals through a partnership programme. In this treatment, a patient’s own T-cells are taken, changed in a lab, and put back in to fight blood cancer. It has produced remission in patients with relapsed ALL and large B-cell lymphoma where all other treatments had failed.

Proton Therapy: India’s Specialist Centres

Proton therapy uses radiation that stops right at the tumour. It protects the healthy tissue around it. This makes it useful for brain tumours, skull-base cancers, children’s cancer cases, and cancers near the spinal cord. Proton therapy is not yet available in Australia. Australian patients who need it are sent to Japan, Singapore, or the USA.

In India, Apollo Proton Cancer Centre in Chennai is the first proton therapy facility in South Asia. A full course costs ₹15,00,000–₹35,00,000 ($18,000–$42,000). At US centres, the same treatment costs USD $100,000–$150,000 or similar prices in Europe. For Australian patients who need proton therapy and cannot get it at home, Apollo Proton Cancer Centre Chennai is a sound and cost-effective option.

Cancer Treatment Cost in India vs Australia: The Full Comparison

The table below compares private-healthcare costs in Australia and international patient package rates at India’s JCI/NABH hospitals. Australian public oncology through Medicare and PBS gives big subsidies to eligible patients — where public access is available in a reasonable time, that should come first. The comparison matters most if you: face long public wait times; need treatments not covered by PBS (some targeted drugs, proton therapy); or are paying out of pocket without full private insurance.

Treatment	India (₹ / USD)	Australia (AUD / USD)	UK (GBP / USD)
Chemotherapy (per cycle).	₹10,000–₹2,00,000 ($106–$2,400)	AUD $20,000–$30,000 ($13,00–$20,000) [Private; PBS subsidises for eligible]	£4,000–£14,000 ($5,500–$18,000)
Major Surgery (e.g., mastectomy, colectomy).	₹1,50,000–₹6,00,000 ($1,800–$7,200)	AUD $15,000–$25,000 ($9,900–$16,000)	£5,000–£17,000 ($6,700–$22,000)
Radiation Therapy (full course).	₹1,50,000–₹10,00,000 ($1,800–$12,000)	AUD $12,000–$25,000 ($8,000–$16,500)	£10,000–£30,000 ($12,000–$38,000)
Targeted Therapy (per month).	₹50,000–₹3,00,000 ($600–$3,600)	AUD $5,000–$11,000+ (PBS may subsidise approved indications).	£7,500–£25,000 ($9,500–$32,000)
Proton Therapy (full course).	₹25,00,000–₹50,00,000 ($30,000–$60,000)	Not widely available in AU; patients travel to USA/Japan.	Limited NHS availability; private: £50,000–£100,000+
Immunotherapy (per cycle).	₹1,50,000–₹4,50,000 ($1,800–$5,500)	AUD $5,000–$15,000 (PBS subsidises approved agents).	£9,000–£30,000 ($12,000–$40,200)

 

All figures are approximate 2025–2026 private-healthcare ranges. Australian PBS subsidies significantly reduce out-of-pocket costs for eligible patients for many standard chemotherapy and immunotherapy drugs. India costs reflect international patient packages at JCI/NABH-accredited partner hospitals. Actual treatment cost depends on cancer type, stage, and individual response. Always request an itemised written quote from your treating hospital before committing to a plan.

A full cancer treatment course in India — surgery + chemotherapy + radiation for breast cancer Stage II-III — typically costs ₹8,00,000–₹20,00,000 ($9,600–$24,000). The same private programme in Australia can reach AUD $60,000–$200,000+ depending on treatment length and complexity. This cost gap is the main reason Australian patients look at Indian treatment.

Best Cancer Hospitals in India for International Patients

 

Hospital	Location & Oncology Strengths	Accreditation	International Patient Services
Apollo Hospitals Chennai	Chennai — comprehensive oncology, bone marrow transplant, proton therapy access	JCI + NABH	Dedicated international dept.; English coordinators
Medanta – The Medicity	Gurgaon (Delhi NCR) — Cancer Institute with surgical, medical, radiation oncology; robotic surgery	JCI + NABH	International patient lounge; visa support; telemedicine
Fortis Memorial Research Institute	Gurgaon (Delhi NCR) — haematological cancers, BMT, head & neck surgery	JCI + NABH	International coordinators; AU-compatible records format
MAX Healthcare	Delhi — breast, lung, GI and gynaecological oncology; PET-CT-guided biopsy	NABH	English-speaking oncology nurse navigators
Artemis Hospitals	Gurgaon (Delhi NCR) — radiation oncology, LINAC-based IMRT/SBRT, oncosurgery	NABH	Medical tourism package coordination

 

All partner hospitals hold current JCI and/or NABH accreditation. International patient coordinators are available at all listed hospitals. Treatment records are issued in English. Divinheal arranges teleconsultation, visa documentation, and accommodation for all partner hospitals. Verify current accreditation status before booking at jointcommissioninternational.org.

For Australian patients, the most practical partner hospitals are in Delhi NCR — Medanta Gurgaon, Fortis Noida, MAX Delhi, and Artemis Gurgaon. These are well-served by direct or one-stop flights from Sydney, Melbourne, Brisbane, and Perth. Apollo Hospitals Chennai is the best choice if you need proton therapy, a bone marrow transplant, or highly specialised head and neck surgery.

A note on oncologists: Divinheal will send you a specialist CV before any booking is confirmed. Many senior oncologists at partner hospitals hold extra fellowships from the Royal College of Radiologists (UK), the American Board of Internal Medicine (oncology), or ESMO. Your Australian GP can check these credentials. At a minimum, ask for the name, qualifications, and case volume of the oncologist who will lead your treatment.

What Is the Hardest Cancer to Cure?

Some cancers remain very hard to treat, even after decades of research. Knowing this helps patients ask the right questions and consider second opinions. The cancer types below have the lowest 5-year survival rates worldwide, based on SEER (Surveillance, Epidemiology, and End Results) data from the US National Cancer Institute.

Pancreatic cancer has a 5-year survival rate of about 12% across all stages. For stage I, it rises to only 42% — but fewer than 10% of cases are caught that early. Pancreatic cancer rarely causes symptoms in early stages. Poor outcomes come from late detection and resistance to most chemotherapy. FOLFIRINOX and gemcitabine/nab-paclitaxel have improved median survival. PARP inhibitor therapy has shown benefit in patients with BRCA mutations.

Glioblastoma multiforme (GBM) is an aggressive brain tumour. Even with standard treatment — surgery + temozolomide + radiation — median survival is 15–18 months. Some patients live longer with immunotherapy trials and tumour-treating fields (TTFields) devices. Apollo Hospitals Chennai and Medanta Gurgaon both have neurosurgical teams with experience in GBM surgery.

Mesothelioma is cancer of the lung lining. It is usually caused by asbestos exposure and has a 5-year survival rate of about 10%. Immunotherapy — the pembrolizumab/ipilimumab combination — has improved response rates as a first-line treatment. This is relevant for Australian patients: Australia has one of the highest mesothelioma rates in the world due to widespread asbestos use in the past.

One important point: these are population-level statistics. Your outcome depends on your stage at diagnosis, your cancer’s molecular type, your overall health, and your treating centre’s experience. Patients with so-called ‘incurable’ cancers regularly outlive the statistics — especially those with access to clinical trials or newer treatments.

Travelling From Australia to India for Cancer Treatment

Visa, Flight, and Pre-Arrival Planning

Australian citizens travelling to India for medical treatment need an Indian e-Medical Visa. Apply online at indianvisaonline.gov.in. You will need a hospital invitation letter from your Indian hospital — Divinheal provides this as part of onboarding. If a partner or family member travels with you, they need a medical attendant e-Visa. Most Australian passport holders get the e-Medical Visa within 5–10 working days.

Direct flights from Sydney and Melbourne to Delhi (Indira Gandhi International) take about 11–13 hours. Chennai is one connection away via Singapore, Kuala Lumpur, or Dubai. Most oncology programmes at partner hospitals run for 3–6 weeks for the active treatment phase. Follow-up after that is done by telemedicine from Australia.

What a Typical India Oncology Journey Looks Like

Weeks 1–2: You arrive, confirm your diagnosis, and plan your treatment. This includes re-staging scans, a pathology review, a tumour board discussion, and a final treatment plan. Most Indian JCI hospitals can complete all pre-treatment checks in 5–7 days — including biopsy, PET-CT, MRI, and molecular test results. Divinheal books all tests before you travel. Your first week will be productive, not wasted.

Weeks 3–6+: Active treatment. Surgery is usually a 1–5 day hospital stay, depending on the procedure. Chemotherapy is given on a day-patient basis. Radiation therapy needs daily or near-daily sessions for 3–6 weeks. Targeted therapy and immunotherapy are outpatient infusion appointments.

Post-treatment: Most patients fly home after finishing active treatment and spending 3–5 recovery days at the hospital or nearby. After that, follow-up is handled by telemedicine with your Indian oncologist plus regular check-ups with your Australian GP and oncologist. Divinheal coordinates the full discharge summary. It is formatted to work with Australian medical record systems.

Support for Australian Patients in India

All Divinheal partner hospitals have international patient departments. These are staffed with English-speaking nurse coordinators who manage appointments, translations, accommodation, and airport transfers. Divinheal also gives you a dedicated coordinator — reachable on WhatsApp throughout your stay — who can raise any clinical or logistical concern directly with the hospital. Psychological support for patients and family members is available at Apollo, Medanta, and Fortis.

Medical travel insurance is strongly recommended. Standard policies do not cover planned procedures. A specialist medical travel insurance policy — from providers like AHM, nib Travel, or Allianz Partners — covers unexpected complications, extended stays, and evacuation if needed. Annual premiums for oncology cover typically run AUD $400–$1,200 depending on the level of cover.

What to Expect After Cancer Treatment: Recovery and Follow-Up

Recovery Timelines by Treatment Type

Recovery from cancer treatment varies a lot. It depends on cancer type, stage, treatment intensity, your age, and your health going in. Here are general timeframes as a guide:

·       After major surgery (e.g., colectomy, mastectomy, liver resection): 4–8 weeks before you can safely fly long-haul.

·       After chemotherapy: fatigue and nausea improve 2–4 weeks after the final cycle in most patients. Full energy can take 3–6 months to come back.

·       After radiation therapy: side effects like fatigue and skin changes peak in the final week of treatment. They usually clear up over 4–8 weeks.

The emotional recovery — often overlooked — can take longer than the physical recovery. Fear of recurrence is the most common concern among cancer survivors. It peaks around the 6-month and 12-month follow-up scans. All Divinheal partner hospitals offer oncology psychologists and patient support groups during and after active treatment.

Follow-Up Care After Returning to Australia.

When you are discharged from the Indian hospital, you receive a full discharge summary in English. It covers: your confirmed diagnosis and stage, all treatment given (drug names, doses, dates), pathology results, imaging findings, post-treatment advice, and the treating oncologist’s contact details. This document works with Australian electronic medical record systems. It is sent to your nominated Australian GP and oncologist within 48 hours of discharge.

Telemedicine follow-up with your Indian oncologist is standard at Apollo, Medanta, and Fortis — at 1 month, 3 months, and 6 months after treatment. These check-ins cover your local scan results and any concerns about ongoing side effects. If you need ongoing targeted therapy or maintenance immunotherapy, your Australian oncologist will prescribe locally, guided by the Indian treatment plan.

How Divinheal Connects Australian Patients to India’s Best Oncology Centres

Divinheal’s role is specific. It connects Australian cancer patients to the right JCI-accredited Indian hospital for their cancer type and stage. It handles the logistics so the medical journey is as simple as possible. And it makes sure clinical information flows clearly between your Indian team and your Australian care providers.

The process starts with a teleconsultation — usually within 5–7 working days of first contact. You share your pathology reports, imaging results, and treatment history. Divinheal’s clinical team sends these to oncology specialists at two or three partner hospitals that match your case. Written second opinions come back within 5–7 working days. No patient travels without a confirmed treatment plan, a cost estimate, and a confirmed appointment date.

For Australian patients with a new cancer diagnosis, Divinheal can also arrange second opinions from Indian oncology specialists without any travel needed. The full assessment is done remotely. This is useful if you have a complex diagnosis and want to check your proposed treatment plan against another team’s view before committing to a path.

Ready to Explore Your Options?

A Divinheal consultation is free. It starts with a review of your pathology reports and imaging. Within 5–7 working days, you get written treatment plan recommendations from two or three specialist oncologists at JCI-accredited Indian hospitals, plus an itemised cost estimate. No travel commitment is needed at this stage.

Australian patients from Sydney, Melbourne, Brisbane, Perth, and Adelaide have used Divinheal to access cancer treatment at Apollo, Medanta, Fortis, MAX, and Artemis. Contact a Divinheal coordinator to request your free oncology consultation today.